-- Seed data for Medications, Antidotes, and MedicationReferences --

INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('dopamine', 'Dopamine', 'Intropin', 'Vasopressor', 'Shock, hypotension, heart failure', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer antidote (Phentolamine preferred). Monitor site.', 'Vasoconstriction', NULL, NULL, NULL, NULL, datetime('now'), 1, 'dopamine intropin vasopressor shock, hypotension, heart failure vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('dopamine', 'Phentolamine', 'First Choice', 'Dilute 5-10 mg in 10-15 mL NS. Inject subcutaneously around site.', NULL, NULL, 'https://pubmed.ncbi.nlm.nih.gov/24420913/');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('dopamine', 'Terbutaline', 'Second Choice', 'Inject 1 mg diluted in 10 mL NS subcutaneously around site.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('dopamine', 'Nitroglycerin Ointment/Patch', 'Second Choice', 'Apply 2% ointment or patch topically.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('dopamine', 'Main Reference for Dopamine', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('dopamine', 'Reference for Antidote: Phentolamine', 'https://pubmed.ncbi.nlm.nih.gov/24420913/');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('doxorubicin', 'Doxorubicin', 'Adriamycin', 'Anthracycline Antineoplastic', 'Various cancers including breast, bladder, lymphoma', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply COLD compress intermittently (e.g., 15-20 min q4-6h for 24-48h). Elevate extremity. Administer antidote (Dexrazoxane preferred). Avoid pressure. Monitor closely for necrosis.', 'Cytotoxicity (DNA binding)', NULL, NULL, NULL, NULL, datetime('now'), 1, 'doxorubicin adriamycin anthracycline antineoplastic various cancers including breast, bladder, lymphoma vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('doxorubicin', 'Dexrazoxane (Totect)', 'First Choice', 'Administer IV as per specific protocol within 6 hours of extravasation.', NULL, NULL, 'https://pubmed.ncbi.nlm.nih.gov/17577013/');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('doxorubicin', 'Dimethyl sulfoxide (DMSO)', 'Second Choice', 'Apply topically 50-99% solution to area q6h for 7-14 days. Allow to air dry.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('doxorubicin', 'Main Reference for Doxorubicin', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('doxorubicin', 'Reference for Antidote: Dexrazoxane (Totect)', 'https://pubmed.ncbi.nlm.nih.gov/17577013/');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('calcium_chloride', 'Calcium Chloride', NULL, 'Electrolyte', 'Hypocalcemia, cardiac arrest', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor for calcification (consider Sodium Thiosulfate if present).', 'Osmolarity (>900 mOsm/L), Precipitation', NULL, NULL, NULL, NULL, datetime('now'), 1, 'calcium chloride electrolyte hypocalcemia, cardiac arrest vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('calcium_chloride', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('calcium_chloride', 'Sodium Thiosulfate', 'Alternative', 'Consider for calcification. Inject SC or IV as per protocol.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('calcium_chloride', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('vancomycin', 'Vancomycin', 'Vancocin', 'Glycopeptide Antibiotic', 'MRSA infections, C. difficile colitis (oral)', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'pH (2.5-4.5)', NULL, NULL, NULL, NULL, datetime('now'), 1, 'vancomycin vancocin glycopeptide antibiotic mrsa infections, c. difficile colitis (oral) vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('vancomycin', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('vancomycin', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('promethazine', 'Promethazine', 'Phenergan', 'Antihistamine, Antiemetic', 'Nausea, vomiting, motion sickness, sedation', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'pH (4.0-5.5), Cytotoxicity', NULL, NULL, NULL, NULL, datetime('now'), 1, 'promethazine phenergan antihistamine, antiemetic nausea, vomiting, motion sickness, sedation vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('promethazine', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('promethazine', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('acyclovir', 'Acyclovir', 'Zovirax', 'Antiviral', 'Herpes virus infections (HSV, VZV)', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'pH (11)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'acyclovir zovirax antiviral herpes virus infections (hsv, vzv) vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('acyclovir', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('acyclovir', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('calcium_gluconate', 'Calcium Gluconate', NULL, 'Electrolyte', 'Hypocalcemia, hyperkalemia, magnesium toxicity', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor for calcification (consider Sodium Thiosulfate if present).', 'Osmolarity (~680 mOsm/L), Precipitation', NULL, NULL, NULL, NULL, datetime('now'), 0, 'calcium gluconate electrolyte hypocalcemia, hyperkalemia, magnesium toxicity vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('calcium_gluconate', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('calcium_gluconate', 'Sodium Thiosulfate', 'Alternative', 'Consider for calcification. Inject SC or IV as per protocol.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('calcium_gluconate', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('carboplatin', 'Carboplatin', 'Paraplatin', 'Alkylating Agent (Platinum)', 'Ovarian cancer, lung cancer, other solid tumors', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Irritant', 'Stop infusion. Remove cannula. Apply COLD compress. Elevate extremity. Monitor site. Consider Sodium Thiosulfate for significant extravasation.', 'Irritant (potential for inflammation)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'carboplatin paraplatin alkylating agent (platinum) ovarian cancer, lung cancer, other solid tumors irritant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('carboplatin', 'Sodium Thiosulfate', 'Considered', 'Inject SC or IV as per protocol for platinum agents.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('carboplatin', 'Main Reference for Carboplatin', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('carmustine', 'Carmustine (BCNU)', 'BiCNU', 'Alkylating Agent (Nitrosourea)', 'Brain tumors, lymphoma, multiple myeloma', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula. Attempt aspiration. Inject Sodium Bicarbonate antidote through cannula and SC. Remove cannula. Apply COLD compress. Elevate extremity. Monitor site.', 'Cytotoxicity (Alkylating)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'carmustine (bcnu) bicnu alkylating agent (nitrosourea) brain tumors, lymphoma, multiple myeloma vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('carmustine', 'Sodium Bicarbonate 8.4%', 'First Choice', 'Inject 2-5 mL IV through existing cannula, then SC around site.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('carmustine', 'Reference for Antidote: Sodium Bicarbonate 8.4%', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('chlorothiazide', 'Chlorothiazide', 'Diuril', 'Thiazide Diuretic', 'Edema, hypertension', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'pH (9.2-10)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'chlorothiazide diuril thiazide diuretic edema, hypertension vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('chlorothiazide', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('chlorothiazide', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('cyclophosphamide', 'Cyclophosphamide', 'Cytoxan', 'Alkylating Agent (Nitrogen Mustard)', 'Leukemia, lymphoma, breast cancer, autoimmune diseases', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Irritant', 'Stop infusion. Remove cannula. Apply COLD compress. Elevate extremity. Monitor site.', 'Irritant', NULL, NULL, NULL, NULL, datetime('now'), 0, 'cyclophosphamide cytoxan alkylating agent (nitrogen mustard) leukemia, lymphoma, breast cancer, autoimmune diseases irritant');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('cyclophosphamide', 'Main Reference for Cyclophosphamide', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('dacarbazine', 'Dacarbazine', 'DTIC-Dome', 'Alkylating Agent', 'Melanoma, Hodgkin lymphoma', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Remove cannula. Apply COLD compress. Elevate extremity. Monitor site.', 'Cytotoxicity (Alkylating)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'dacarbazine dtic-dome alkylating agent melanoma, hodgkin lymphoma vesicant');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('dacarbazine', 'Main Reference for Dacarbazine', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('dactinomycin', 'Dactinomycin', 'Cosmegen', 'Antitumor Antibiotic', 'Wilms tumor, rhabdomyosarcoma, Ewing sarcoma', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Remove cannula. Apply COLD compress. Elevate extremity. Monitor site. Consider Sodium Thiosulfate.', 'Cytotoxicity (DNA intercalation)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'dactinomycin cosmegen antitumor antibiotic wilms tumor, rhabdomyosarcoma, ewing sarcoma vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('dactinomycin', 'Sodium Thiosulfate', 'Considered', 'Inject SC or IV as per protocol.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('dactinomycin', 'Main Reference for Dactinomycin', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('daunorubicin', 'Daunorubicin', 'Cerubidine', 'Anthracycline Antineoplastic', 'Acute leukemias (AML, ALL)', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply COLD compress intermittently. Elevate extremity. Administer antidote (Dexrazoxane preferred). Avoid pressure. Monitor closely.', 'Cytotoxicity (DNA binding)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'daunorubicin cerubidine anthracycline antineoplastic acute leukemias (aml, all) vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('daunorubicin', 'Dexrazoxane (Totect)', 'First Choice', 'Administer IV as per specific protocol within 6 hours of extravasation.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('daunorubicin', 'Dimethyl sulfoxide (DMSO)', 'Second Choice', 'Apply topically 50-99% solution to area q6h for 7-14 days. Allow to air dry.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('daunorubicin', 'Reference for Antidote: Dimethyl sulfoxide (DMSO)', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('dextrose_gt10', 'Dextrose >10%', NULL, 'Caloric Agent', 'Hypoglycemia, fluid/calorie replacement', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'Osmolarity (>505 mOsm/L for 10%)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'dextrose >10% caloric agent hypoglycemia, fluid/calorie replacement vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('dextrose_gt10', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('dextrose_gt10', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('dobutamine', 'Dobutamine', 'Dobutrex', 'Beta-1 Agonist, Inotrope', 'Heart failure, cardiogenic shock', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer antidote (Phentolamine preferred). Monitor site.', 'Vasoconstriction (mild alpha-1 effect), Cytotoxicity', NULL, NULL, NULL, NULL, datetime('now'), 0, 'dobutamine dobutrex beta-1 agonist, inotrope heart failure, cardiogenic shock vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('dobutamine', 'Phentolamine', 'First Choice', 'Dilute 5-10 mg in 10-15 mL NS. Inject subcutaneously around site.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('dobutamine', 'Terbutaline', 'Second Choice', 'Inject 1 mg diluted in 10 mL NS subcutaneously around site.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('dobutamine', 'Nitroglycerin Ointment/Patch', 'Second Choice', 'Apply 2% ointment or patch topically.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('dobutamine', 'Reference for Antidote: Nitroglycerin Ointment/Patch', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('docetaxel', 'Docetaxel', 'Taxotere', 'Taxane Antineoplastic', 'Breast, lung, prostate, gastric, head/neck cancer', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Vesicant', 'Stop infusion. Remove cannula. Apply COLD compress. Elevate extremity. Monitor site. Hyaluronidase may be considered.', 'Cytotoxicity (Microtubule inhibitor)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'docetaxel taxotere taxane antineoplastic breast, lung, prostate, gastric, head/neck cancer vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('docetaxel', 'Hyaluronidase', 'Considered', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('docetaxel', 'Main Reference for Docetaxel', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('epinephrine', 'Epinephrine', 'Adrenalin', 'Vasopressor, Bronchodilator', 'Anaphylaxis, cardiac arrest, shock, asthma', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer antidote (Phentolamine preferred). Monitor site.', 'Vasoconstriction (Alpha-1)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'epinephrine adrenalin vasopressor, bronchodilator anaphylaxis, cardiac arrest, shock, asthma vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('epinephrine', 'Phentolamine', 'First Choice', 'Dilute 5-10 mg in 10-15 mL NS. Inject subcutaneously around site.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('epinephrine', 'Terbutaline', 'Second Choice', 'Inject 1 mg diluted in 10 mL NS subcutaneously around site.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('epinephrine', 'Nitroglycerin Ointment/Patch', 'Second Choice', 'Apply 2% ointment or patch topically.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('epinephrine', 'Main Reference for Epinephrine', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('epirubicin', 'Epirubicin', 'Ellence', 'Anthracycline Antineoplastic', 'Breast cancer', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply COLD compress intermittently. Elevate extremity. Administer antidote (Dexrazoxane preferred). Avoid pressure. Monitor closely.', 'Cytotoxicity (DNA binding)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'epirubicin ellence anthracycline antineoplastic breast cancer vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('epirubicin', 'Dexrazoxane (Totect)', 'First Choice', 'Administer IV as per specific protocol within 6 hours of extravasation.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('epirubicin', 'Dimethyl sulfoxide (DMSO)', 'Second Choice', 'Apply topically 50-99% solution to area q6h for 7-14 days. Allow to air dry.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('epirubicin', 'Reference for Antidote: Dimethyl sulfoxide (DMSO)', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('esmolol', 'Esmolol', 'Brevibloc', 'Beta-Blocker (Cardioselective)', 'Supraventricular tachycardia, hypertension', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'pH (4.5-6.5)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'esmolol brevibloc beta-blocker (cardioselective) supraventricular tachycardia, hypertension vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('esmolol', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('esmolol', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('etoposide', 'Etoposide', 'VePesid, Toposar', 'Topoisomerase II Inhibitor', 'Testicular cancer, lung cancer, lymphoma', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Irritant', 'Stop infusion. Remove cannula. Apply WARM compress. Elevate extremity. Monitor site. Hyaluronidase may be considered.', 'Irritant', NULL, NULL, NULL, NULL, datetime('now'), 0, 'etoposide vepesid, toposar topoisomerase ii inhibitor testicular cancer, lung cancer, lymphoma irritant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('etoposide', 'Hyaluronidase', 'Considered', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('etoposide', 'Main Reference for Etoposide', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('idarubicin', 'Idarubicin', 'Idamycin', 'Anthracycline Antineoplastic', 'Acute myeloid leukemia (AML)', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply COLD compress intermittently. Elevate extremity. Administer antidote (Dexrazoxane preferred). Avoid pressure. Monitor closely.', 'Cytotoxicity (DNA binding)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'idarubicin idamycin anthracycline antineoplastic acute myeloid leukemia (aml) vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('idarubicin', 'Dexrazoxane (Totect)', 'First Choice', 'Administer IV as per specific protocol within 6 hours of extravasation.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('idarubicin', 'Dimethyl sulfoxide (DMSO)', 'Second Choice', 'Apply topically 50-99% solution to area q6h for 7-14 days. Allow to air dry.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('idarubicin', 'Main Reference for Idarubicin', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('lorazepam', 'Lorazepam', 'Ativan', 'Benzodiazepine', 'Anxiety, status epilepticus, sedation', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'Osmolarity (>2000 mOsm/L), Solvent (propylene glycol)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'lorazepam ativan benzodiazepine anxiety, status epilepticus, sedation vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('lorazepam', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('lorazepam', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('mannitol_10_20', 'Mannitol 10%-20%', 'Osmitrol', 'Osmotic Diuretic', 'Cerebral edema, increased intraocular pressure', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site. Check for crystal formation before administration.', 'Osmolarity (>1100 mOsm/L for 20%)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'mannitol 10%-20% osmitrol osmotic diuretic cerebral edema, increased intraocular pressure vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('mannitol_10_20', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('mannitol_10_20', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('mechlorethamine', 'Mechlorethamine', 'Mustargen', 'Alkylating Agent (Nitrogen Mustard)', 'Hodgkin lymphoma, non-Hodgkin lymphoma', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula. Attempt aspiration. Inject Sodium Thiosulfate antidote through cannula and SC. Remove cannula. Apply COLD compress. Elevate extremity. Monitor site.', 'Cytotoxicity (Alkylating)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'mechlorethamine mustargen alkylating agent (nitrogen mustard) hodgkin lymphoma, non-hodgkin lymphoma vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('mechlorethamine', 'Sodium Thiosulfate', 'First Choice', 'Inject 2 mL of 1/6 M solution SC for each mg extravasated.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('mechlorethamine', 'Main Reference for Mechlorethamine', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('methocarbamol', 'Methocarbamol', 'Robaxin', 'Muscle Relaxant', 'Muscle spasms', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'pH (3.5-6), Solvent (polyethylene glycol)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'methocarbamol robaxin muscle relaxant muscle spasms vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('methocarbamol', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('methocarbamol', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('methotrexate', 'Methotrexate', 'Trexall, Rheumatrex', 'Antimetabolite, DMARD', 'Cancer, rheumatoid arthritis, psoriasis', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Irritant', 'Stop infusion. Remove cannula. Apply COLD compress. Elevate extremity. Monitor site. Ensure leucovorin rescue is available if high-dose therapy.', 'Irritant (pH dependent)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'methotrexate trexall, rheumatrex antimetabolite, dmard cancer, rheumatoid arthritis, psoriasis irritant');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('methotrexate', 'Main Reference for Methotrexate', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('mitomycin', 'Mitomycin', 'Mutamycin', 'Antitumor Antibiotic', 'Gastric, pancreatic, bladder cancer', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Remove cannula. Apply DMSO topically. Apply COLD compress. Elevate extremity. Monitor site. Delayed tissue reactions can occur.', 'Cytotoxicity (Alkylating)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'mitomycin mutamycin antitumor antibiotic gastric, pancreatic, bladder cancer vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('mitomycin', 'Dimethyl sulfoxide (DMSO)', 'First Choice', 'Apply topically 50-99% solution to area q6h for 14 days. Allow to air dry.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('mitomycin', 'Sodium Thiosulfate', 'Considered', 'Inject SC or IV as per protocol.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('mitomycin', 'Main Reference for Mitomycin', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('mitoxantrone', 'Mitoxantrone', 'Novantrone', 'Anthracenedione Antineoplastic', 'Prostate cancer, AML, multiple sclerosis', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Remove cannula. Apply COLD compress. Elevate extremity. Monitor site. DMSO may be considered.', 'Cytotoxicity (DNA intercalation)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'mitoxantrone novantrone anthracenedione antineoplastic prostate cancer, aml, multiple sclerosis vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('mitoxantrone', 'Dimethyl sulfoxide (DMSO)', 'Considered', 'Apply topically 50-99% solution to area q6h for 7-14 days. Allow to air dry.', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('mitoxantrone', 'Reference for Antidote: Dimethyl sulfoxide (DMSO)', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('nafcillin', 'Nafcillin', 'Unipen', 'Penicillinase-Resistant Penicillin', 'Staphylococcal infections', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'Osmolarity (~300 mOsm/L but concentration dependent), pH (6-8.5)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'nafcillin unipen penicillinase-resistant penicillin staphylococcal infections vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('nafcillin', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('nafcillin', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('norepinephrine', 'Norepinephrine', 'Levophed', 'Vasopressor', 'Shock, severe hypotension', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer antidote (Phentolamine preferred). Monitor site.', 'Vasoconstriction (Alpha-1)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'norepinephrine levophed vasopressor shock, severe hypotension vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('norepinephrine', 'Phentolamine', 'First Choice', 'Dilute 5-10 mg in 10-15 mL NS. Inject subcutaneously around site.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('norepinephrine', 'Terbutaline', 'Second Choice', 'Inject 1 mg diluted in 10 mL NS subcutaneously around site.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('norepinephrine', 'Nitroglycerin Ointment/Patch', 'Second Choice', 'Apply 2% ointment or patch topically.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('norepinephrine', 'Reference for Antidote: Nitroglycerin Ointment/Patch', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('pentamidine', 'Pentamidine', 'Pentam', 'Antiprotozoal', 'Pneumocystis pneumonia (PCP) treatment/prophylaxis', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'pH (4.5-7.5)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'pentamidine pentam antiprotozoal pneumocystis pneumonia (pcp) treatment/prophylaxis vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('pentamidine', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('pentamidine', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('pentobarbital', 'Pentobarbital', 'Nembutal', 'Barbiturate', 'Seizures, sedation, induction of coma', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'pH (9-10.5)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'pentobarbital nembutal barbiturate seizures, sedation, induction of coma vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('pentobarbital', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('pentobarbital', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('phenobarbital', 'Phenobarbital', 'Luminal', 'Barbiturate', 'Seizures, sedation', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'pH (9.2-10.2)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'phenobarbital luminal barbiturate seizures, sedation vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('phenobarbital', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('phenobarbital', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('phenylephrine', 'Phenylephrine', 'Neo-Synephrine', 'Vasopressor (Alpha-1 Agonist)', 'Hypotension, shock', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer antidote (Phentolamine preferred). Monitor site.', 'Vasoconstriction (Alpha-1)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'phenylephrine neo-synephrine vasopressor (alpha-1 agonist) hypotension, shock vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('phenylephrine', 'Phentolamine', 'First Choice', 'Dilute 5-10 mg in 10-15 mL NS. Inject subcutaneously around site.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('phenylephrine', 'Terbutaline', 'Second Choice', 'Inject 1 mg diluted in 10 mL NS subcutaneously around site.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('phenylephrine', 'Nitroglycerin Ointment/Patch', 'Second Choice', 'Apply 2% ointment or patch topically.', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('phenylephrine', 'Reference for Antidote: Nitroglycerin Ointment/Patch', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('phenytoin', 'Phenytoin', 'Dilantin', 'Anticonvulsant', 'Seizures', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site. Risk of ''Purple Glove Syndrome''.', 'pH (10-12.3), Precipitation', NULL, NULL, NULL, NULL, datetime('now'), 0, 'phenytoin dilantin anticonvulsant seizures vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('phenytoin', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('phenytoin', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('sodium_bicarbonate', 'Sodium Bicarbonate', NULL, 'Alkalinizing Agent', 'Metabolic acidosis, hyperkalemia, urine alkalinization', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'Osmolarity (>1000 mOsm/L for 8.4%), pH (7-8.5)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'sodium bicarbonate alkalinizing agent metabolic acidosis, hyperkalemia, urine alkalinization vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('sodium_bicarbonate', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('sodium_bicarbonate', 'Reference for Antidote: Hyaluronidase', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('streptozotocin', 'Streptozotocin', 'Zanosar', 'Alkylating Agent', 'Pancreatic islet cell carcinoma', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Remove cannula. Apply COLD compress. Elevate extremity. Monitor site.', 'Cytotoxicity (Alkylating)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'streptozotocin zanosar alkylating agent pancreatic islet cell carcinoma vesicant');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('streptozotocin', 'Main Reference for Streptozotocin', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('teniposide', 'Teniposide', 'Vumon', 'Topoisomerase II Inhibitor', 'Acute lymphoblastic leukemia (ALL)', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Irritant', 'Stop infusion. Remove cannula. Apply WARM compress. Elevate extremity. Monitor site. Hyaluronidase may be considered.', 'Irritant', NULL, NULL, NULL, NULL, datetime('now'), 0, 'teniposide vumon topoisomerase ii inhibitor acute lymphoblastic leukemia (all) irritant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('teniposide', 'Hyaluronidase', 'Considered', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('teniposide', 'Main Reference for Teniposide', 'https://hemonc.org/wiki/Vesicant_%26_irritant_chemotherapy');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('tobramycin', 'Tobramycin', 'Nebcin', 'Aminoglycoside Antibiotic', 'Gram-negative bacterial infections', NULL, '{"central": true, "peripheral": true, "midline": true}', 'Irritant', 'Stop infusion. Remove cannula. Apply WARM compress. Elevate extremity. Monitor site.', 'Irritant (pH 3-6.5)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'tobramycin nebcin aminoglycoside antibiotic gram-negative bacterial infections irritant');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('tobramycin', 'Main Reference for Tobramycin', 'https://www.mi-hms.org/sites/default/files/Medications%20with%20Irritant%20or%20Vesicant%20Properties.pdf');
INSERT INTO Medications (id, name, brand_name, drug_class, indication, administration_recommendations, line_requirements, extravasation_risk, extravasation_management, mechanism_of_injury, dosage_considerations, preparation_guidelines, administration_guidelines, evidence_level, last_updated, is_free, search_terms) VALUES ('tpn', 'TPN (Total Parenteral Nutrition)', NULL, 'Nutritional Support', 'Inability to use GI tract for nutrition', NULL, '{"central": true, "peripheral": false, "midline": false}', 'Vesicant', 'Stop infusion. Leave cannula initially. Attempt aspiration. Apply WARM compress. Elevate extremity. Administer Hyaluronidase. Monitor site.', 'Osmolarity (>900 mOsm/L)', NULL, NULL, NULL, NULL, datetime('now'), 0, 'tpn (total parenteral nutrition) nutritional support inability to use gi tract for nutrition vesicant');
INSERT INTO Antidotes (medication_id, name, priority, preparation, administration, evidence_level, reference) VALUES ('tpn', 'Hyaluronidase', 'First Choice', 'Inject 150 units/mL (diluted in NS) SC into 5 sites around area (0.2 mL per site).', NULL, NULL, 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
INSERT INTO MedicationReferences (medication_id, citation, url) VALUES ('tpn', 'Main Reference for TPN (Total Parenteral Nutrition)', 'https://journals.lww.com/journalofinfusionnursing/fulltext/2020/11000/recommendations_for_management_of_noncytotoxic.3.aspx');
